Characteristics of NDM-1-producing Escherichia coli isolates that belong to the successful and virulent clone ST131

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 6, 2011, Pages 2986-2988

  Peirano, Gisele ^a   Schreckenberger, Paul C ^b   Pitout, Johann D D ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; BETA LACTAMASE; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; ERTAPENEM; GENTAMICIN; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; NDM 1; NITROFURANTOIN; PIPERACILLIN PLUS TAZOBACTAM; SULFADOXINE PLUS TRIMETHOPRIM; TOBRAMYCIN; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CANADA; CASE REPORT; ESCHERICHIA COLI; GENE SEQUENCE; HOSPITALIZATION; HUMAN; INDIA; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; SEQUENCE TYPE 131; UNITED STATES; URINARY TRACT INFECTION;

ADULT; BETA-LACTAMASES; ESCHERICHIA COLI; HUMANS; MALE; PHYLOGENY; POLYMERASE CHAIN REACTION; URINARY TRACT INFECTIONS; VIRULENCE;

EID: 79956302864     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01763-10     Document Type: Article

References (24)

1. Anonymous. 2010. Detection of Enterobacteriaceae isolates carrying metallo-beta-lactamase - United States, 2010. MMWR Morb. Mortal. Wkly. Rep. 59:750.
2. Boyd, D. A., et al. 2004. Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extended-spectrum beta-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada. Antimicrob. Agents Chemother. 48:3758-3764.
3. Carattoli, A., et al. 2005. Identification of plasmids by PCR-based replicon typing. J. Microbiol. Methods 63:219-228. (Pubitemid 41597366)
4. Clermont, O., S. Bonacorsi, and E. Bingen. 2000. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66:4555-4558.
5. Clermont, O., et al. 2009. Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J. Antimicrob. Chemother. 64:274-277.
6. Clinical and Laboratory Standards Institute. 2010. Performance standards for antimicrobial susceptibility testing; 20th informational supplement M100-S20-U. CLSI, Wayne, PA.
7. Cornaglia, G., et al. 2007. Metallo-beta-lactamases as emerging resistance determinants in Gram-negative pathogens: open issues. Int. J. Antimicrob. Agents 29:380-388.
8. Johnson, J. R., B. Johnston, C. Clabots, M. A. Kuskowski, and M. Castanheira. 2010. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin. Infect. Dis. 51:286-294.
9. Johnson, J. R., et al. 2009. Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob. Agents Chemother. 53:2733-2739.
10. Johnson, J. R., and A. L. Stell. 2000. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J. Infect. Dis. 181:261-272.
11. Kumarasamy, K. K., et al. 2010. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect. Dis. 10:597-602.
12. Leverstein-Van Hall, M. A., et al. 2010. Global spread of New Delhi metallobeta-lactamase 1. Lancet Infect. Dis. 10:830-831.
13. Livermore, D. M., and N. Woodford. 2006. The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter. Trends Microbiol. 14:413-420. (Pubitemid 44233298)
14. Peirano, G., J. Ahmed-Bentley, N. Woodford, and J. D. Pitout. 2011. New Delhi metallo-beta-lactamase from traveler returning to Canada. Emerg. Infect. Dis. 17:242-244.
15. Pitout, J. D. 2010. The latest threat in the war on antimicrobial resistance. Lancet Infect. Dis. 10:578-579.
16. Pitout, J. D., et al. 2007. Molecular epidemiology of CTX-M-producing Escherichia coli in the Calgary Health Region: emergence of CTX-M-15-producing isolates. Antimicrob. Agents Chemother. 51:1281-1286.
17. Pitout, J. D., K. B. Laupland, D. L. Church, M. L. Menard, and J. R. Johnson. 2005. Virulence factors of Escherichia coli isolates that produce CTX-M-type extended-spectrum beta-lactamases. Antimicrob. Agents Chemother. 49:4667-4670.
18. Poirel, L., Z. Al Maskari, F. Al Rashdi, S. Bernabeu, and P. Nordmann. 2010. NDM-1-producing Klebsiella pneumoniae isolated in the Sultanate of Oman. J. Antimicrob. Chemother. 66:304-306.
19. Poirel, L., C. Hombrouck-Alet, C. Freneaux, S. Bernabeu, and P. Nordmann. 2010. Global spread of New Delhi metallo-beta-lactamase 1. Lancet Infect. Dis. 10:832.
20. Poirel, L., E. Lagrutta, P. Taylor, J. Pham, and P. Nordmann. 2010. Emergence of metallo-beta-lactamase NDM-1-producing multidrug-resistant Escherichia coli in Australia. Antimicrob. Agents Chemother. 54:4914-4916.
21. Robicsek, A., et al. 2006. Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat. Med. 12:83-88.
22. Robicsek, A., J. Strahilevitz, D. F. Sahm, G. A. Jacoby, and D. C. Hooper. 2006. qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob. Agents Chemother. 50:2872-2874.
23. Yamane, K., J. Wachino, S. Suzuki, and Y. Arakawa. 2008. Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan. Antimicrob. Agents Chemother. 52:1564-1566.
24. Yong, D., et al. 2009. Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob. Agents Chemother. 53:5046-5054.